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Martinez-deMena, Raquel, Arturo Herna´ndez, and
Maria-Jesu´s Obrego´n. Triiodothyronine is required for the
stimulation of type II 5-deiodinase mRNA in rat brown
adipocytes. Am J Physiol Endocrinol Metab 282: E1119–E1127,
2002; 10.1152/ajpendo.00433.2001.—Type II 5-iodothyronine
deiodinase (D2), produces triiodothyronine (T3) and is stimu-
lated by cold exposure via norepinephrine (NE) release in
brown adipose tissue. Cultured rat brown adipocytes require T3
for the adrenergic stimulation of D2 activity. D2 mRNA expres-
sion in cultured brown adipocytes is undetectable with the use
of basal conditions or NE without T3. Full D2 expression is
achieved using NET3, especially after prolonged T3 exposure.
3-Adrenergic agonists mimic the NE action, whereas cAMP
analogs do not. Prolonged exposure to T3 alone increases D2
mRNA. High T3 doses (500 nM) inhibit the adrenergic stimu-
lation of D2 activity while increasing D2 mRNA. The effects
obtained with NE  T3 or T3 alone are suppressed by actino-
mycin, but not by cycloheximide, which leads to accumulation of
short D2 mRNA transcripts. Prolonged or short exposure to T3
did not change D2 mRNA half-life, but T3 seemed to elongate it.
In conclusion, T3 is an absolute requirement for the adrenergic
stimulation of D2 mRNA in brown adipocytes. T3 upregulates
D2 mRNA, an effect that might involve stimulation of factors
required for transcription or for stabilization of D2 mRNA.
norepinephrine; uncoupling protein-1
BROWN ADIPOSE TISSUE (BAT) is a thermogenic tissue
specialized in the production of heat in demanding
situations such as cold exposure, during arousal from
hibernation, or by the cold experienced after birth. This
process is called facultative thermogenesis. The pro-
duction of heat is accomplished by a mitochondrial
protein, called uncoupling protein-1 (UCP1), the spe-
cific marker of BAT. Adrenergic stimulation is the
main effector for the activation of UCP1, and thyroid
hormones, specifically triiodothyronine (T3), have been
described as being necessary for the full expression of
UCP1 in rats (3, 4). Moreover, T3 in BAT is locally
produced from thyroxine (T4) via a deiodinase that
plays an important role generating the T3 required for
UCP1 expression (5).
The deiodinases are enzymes that regulate thyroid
hormone availability in peripheral tissues. Three dif-
ferent deiodinases have been described that catalyze
outer- and inner-ring deiodination. Outer-ring deiodi-
nation is a key pathway of thyroid hormone metabo-
lism that leads to the production of T3, whereas inner-
ring deiodination results in the formation of inactive
compounds. Most of the T3 present in tissues is pro-
duced from T4 via outer ring 5-deiodination. Two
isoenzymes catalyze this activating pathway: type I
and type II 5-iodothyronine deiodinases (D1 and D2).
D1 and D2 differ in their kinetic characteristics, sen-
sitivity to inhibition by 6-N-propyl-2-thiouracil (PTU),
tissular distribution, and response to thyroid status
(23). Different from D1, D2 is insensitive to PTU, it
prefers T4 as substrate, and its Michaelis-Menten con-
stant is in the nanomolar range. D2 activity is upregu-
lated in hypothyroidism and inhibited by T4 (26, 47,
48). D2 activity is localized in brain, adenohypophysis,
BAT, pineal gland, and the maternal side of the pla-
centa, among other tissues (24, 26, 39, 44, 53). D2
activity is regulated in rat tissues, glial cells, or brown
adipocytes by a number of factors such as thyroid
hormones (26, 27, 47), adrenergic agents (19, 22, 32, 35,
38, 39, 44), cAMP (10, 17, 22), growth factors (11), and
insulin (29, 46).
The cDNAs coding for the three deiodinases have
been isolated in rat, human, and other species (2, 12,
13). Sequence analysis has demonstrated that all of
them contain an in-frame TGA codon that is translated
as selenocysteine due to the presence of a specific
structure, named selenocysteine insertion sequence
(SECIS), in the 3 untranslated region of their mRNAs
(2, 6). Analysis of D2 expression in human tissues has
shown that D2 is also present in human heart, skeletal
muscle, and thyroid (12, 42).
In rat BAT, D2 activity is stimulated by hypothyroid-
ism (27) and by cold exposure, norepinephrine (NE),
and adrenergic stimuli (44). T3-induced hyperthyroid-
ism augmented the response to NE (47). These situa-
tions also increase D2 mRNA levels (12). As already
mentioned, D2 activity produces most of the T3 found
in BAT (45), which saturates nuclear T3 receptors, and
the T3 produced is necessary for a complete thermo-
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genic function, namely the full expression of the un-
coupling protein UCP1, specific marker of BAT (5).
Besides, BAT D2 activity is upregulated by insulin
(46), as shown after insulin injection, or in diabetic
rats, as well as in floating rat brown adipocytes (29). In
these cells, D2 activity is stimulated by adrenergic
agents, and a synergy between 1- and -adrenergic
pathways has been described (32, 38), whereas in cul-
tures of mouse brown adipocytes the main pathway is
-adrenergic (35).
Using primary cultures of rat brown adipocytes, we
have previously shown that D2 activity is poorly stim-
ulated by NE or cAMP analogs and that T3 is required
for and amplifies the adrenergic response 10- to 20-fold
(19). The effect of T3 is exerted when NE or 3-adren-
ergic agents are used and is only poorly mimicked
when cAMP-elevating agents are used. The stimula-
tory effect of T3 on the adrenergic responses of D2
activity overcomes the inhibition caused by T4, and
such increases are proportional to the time of preexpo-
sure to T3 (19). The T3  NE effect requires de novo
protein synthesis and is fully inhibited by actinomycin.
In the present study, we have studied the regulation
of D2 mRNA expression by adrenergic stimulation and
by T3 by use of primary cultures of rat brown adipo-
cytes differentiated in culture from preadipocytes. Our
results disclose a novel role of T3 in the regulation of
D2 mRNA levels, both in cooperation with NE and by
itself, indicating the importance of T3 for the brown
adipocyte.
MATERIALS AND METHODS
Materials. The source of most of the reagents used has
been previously described (21). Newborn calf serum (NCS)
was purchased from Flow (Paisley, Scotland) or from GIBCO
Life Technologies (Uxbridge, UK). Isoproterenol (ISO) and
8-bromoadenosine 3,5-cyclic monophosphate (8-BrcAMP)
were obtained from Sigma Chemical (St. Louis, MO). BRL-
37344 was kindly provided by SmithKline Beecham Pharma-
ceuticals (Welwyn, UK). Ion exchange resins AG1-X8 and
AG50W-X2 were obtained from Bio-Rad (Richmond, CA).
Oligo(dT) cellulose was obtained from New England Biolabs
(Beverly, MA), TRIzol from GIBCO-BRL Life Technologies,
AmpliTaq Gold DNA polymerase from Roche Molecular Sys-
tems (Branchburg, NJ), and AMV reverse transcriptase (RT)
from Promega (Madison, WI).
Cultures of brown adipocytes. Precursor cells were ob-
tained from the interscapular BAT of 20-day-old rats
(Sprague-Dawley), isolated according to the method de-
scribed by Ne´chad et al. (30) by using collagenase digestion
(0.2%) in DMEM  1.5% BSA at 37°C and filtered through
250-m silk filters. Mature cells were allowed to float, and
the infranatant was filtered through 25-m silk filters and
centrifuged. Precursor cells were seeded in 25-cm2 culture
flasks or 145-cm2 plates at a density of 1,500–2,000 cells/cm2
on day 1 and grown in DMEM supplemented with 10% NCS,
3 nM insulin, 10 mM HEPES, 50 IU of penicillin, and 50 g
of streptomycin/ml and 15 M ascorbic acid. Culture medium
was changed on day 1 and every 2–3 days until the experi-
ment was performed. Precursor cells proliferate actively un-
der these conditions, reach confluence on the 4th or 5th day
after seeding (40,000–60,000 cells/cm2), and then differenti-
ate into mature brown adipocytes. Most studies and treat-
ments were done in fully differentiated brown adipocytes (on
the 9th day after seeding). For deiodinase activity, 25-cm2
flasks were used, and for mRNA studies, 2–3 plates (145
cm2), seeded at the same cellular density, were pooled.
Both NCS and hypothyroid (Hypo) serum were used for
culture. The latter was obtained by depleting NCS of thyroid
hormones with the anion exchange resin AG1-X8, as de-
scribed (43). Hypo serum contained 10% or less of the
original amount of thyroid hormones, as assessed by RIA
(36). In NCS, concentrations of T4 and T3 were 77 and 1.3 nM,
respectively, before its dilution with medium. These levels
decreased to 2.2 nM T4 and 0.13 nM T3 in Hypo serum. In
some experiments, T3 and T4 concentrations were measured
in medium and cells (after purification of the extracts) by
means of specific RIAs (36).
Free T3 concentrations were measured by ultrafiltration as
described (36). Free T3 concentration was 2 or 4% of the total
T3 when 10 or 5% serum, respectively, (either NCS or Hypo
serum) was used. The actual free T3 concentrations were
5–10 pM when 10% NCS was used and 200–500 pM T3 when
10 nM T3 was added to the culture medium supplemented
with 10 or 5% Hypo serum, respectively.
RNA preparation and Northern blot analysis. For the iso-
lation of poly(A) RNA, cells were collected and mRNA
isolated using oligo(dT) cellulose as described (52). For
Northern analysis, poly(A) (5–7 g) was denatured and
electrophoresed on a 2.2 M formaldehyde/1% agarose gel in
1 MOPS buffer (pH 7.0) and transferred to nylon mem-
branes (Nytran) as described (18, 21). A 1.988-kb fragment of
the rat D2 cDNA clone (12), corresponding to the entire
coding region of the rat D2, 580 nucleotides from the 5 region
and 30 nucleotides of the 3 end, was used as a probe by
labeling with [-32P]dCTP with the use of random primers
(108 cpm/g DNA). Filters were hybridized for 20 h at 50°C
[40% formamide, 20 g/ml salmon sperm DNA, 50 g
poly(A), and 50 g poly(C)/ml, 5 saline sodium citrate
(SSC), 2 Denhardt’s, 0.1% SDS] and washed four times in
2 SSC/0.2% SDS at room temperature for 15 min and then
twice in 0.1 SSC/0.2% SDS at 65°C for 20 min. Autoradio-
grams were obtained from the filters and quantified by laser
computer-assisted densitometry (Molecular Dynamics, Sunny-
vale, CA). The filters were hybridized with cyclophilin as a
control to correct for differences between lanes in the amount
of poly(A) mRNA (14). All of the experiments were repeated
2–3 times, using Northern blot analysis in all. The more
complete or representative experiments are shown in the
figures.
RT-PCR assay. One microgram of total RNA (TRIzol,
GIBCO) was used for RT-PCR amplification under the con-
ditions previously described (12). We used the same RNA
samples without RT reaction as controls. The PCR reaction
conditions were 94°C for 5 min, and 35 cycles at 94°C for 1
min, 55°C for 1 min, and 72°C for 1 min, and a final 7-min
period at 72°C, using AmpliTaq Gold DNA polymerase. The
specific oligonucleotides used for amplification of a 590-bp
product were: sense, 5-ACT CGG TCA TTC TGC TCA AG-3
and antisense, 5-TTC AAA GGC TAC CCC ATA AG-3, as
previously described (12). After gel electrophoresis in 1%
agarose, the PCR products were transferred to a filter and
hybridized with a radiolabeled, nested oligonucleotide rat D2
probe (AAT GCC ACC TTC TTG ACT TT), using [	-32P]ATP,
as previously described (12). The optimal conditions were
chosen to avoid the presence of DNA in the samples, unspe-
cific annealing in the PCR reaction, etc.
Determination of D2 activity. Cells were scraped, collected
in buffer A [0.32 M sucrose, 10 mM HEPES, 10 mM dithio-
threitol (DTT), pH 7.0] and homogenized. D2 activities were
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determined in homogenates by measuring the release of
iodide as described (27), with modifications (19, 33), using as
final concentrations 2 nM T4 (50.000 cpm [125I]T4), 1 M T3,
50 mM DTT, 1 mM PTU, 80–100 g protein/100 l of total
volume, pH 7.0, during 1 h at 37°C. In these conditions,
95% of the activity was insensitive to inhibition with PTU.
Each cell homogenate was tested in triplicate using 2–3
culture flasks per treatment. Protein content was determined
by the method of Lowry (28) after precipitation of the homog-
enates with trichloroacetic acid to avoid interference of DTT
in the colorimetric reaction (19). Results were expressed in
femtomoles per hour per milligram of protein.
The high specific activity [125I]T4 used was obtained in our
laboratory (3,000 Ci/g) with the use of chloramine T and
T3 as substrate (19, 33). Before each assay, [125I]T4 was
purified by paper electrophoresis to separate the contaminat-
ing iodide, using ammonium acetate 0.05 M, pH 6.8. The
amount of iodide in the blanks assay was routinely less than
1% of the total radioactivity. Preliminary experiments were
performed to validate the assay: 1) the production of equimo-
lar amounts of iodide and T3, 2) the linear production of
iodide by use of increasing amounts of protein, and 3) the
within-assay coefficient of variation that was 
5%.
Statistical analysis. Mean values SE are given. One-way
analysis of variance (ANOVA) was done, after homogeneity of
variance was ensured, using square roots or logarithmic
transformations if the homogeneity was not found with the
raw data. Significance of differences between groups was
assessed using the protected least significant difference test.
All calculations were done as described (49).
RESULTS
We have previously shown that, in primary cultures
of rat brown adipocytes, the adrenergic stimulation of
D2 activity requires the presence of T3 (19). This T3
requirement is similar to the one observed for the
adrenergic stimulation of UCP1 mRNA in the same cell
model (20).
D2 mRNA induction by NE and T3. In rat BAT, D2
mRNA presents several bands at 7.5, 4.0, 2.5, and 2.0
kb, the first being the most abundant. D2 mRNA ex-
pression is clearly stimulated in the BAT of cold-ex-
posed rats (12). In the present study, we used Northern
blot analysis of poly(A)-enriched mRNA from differ-
entiated brown adipocytes. D2 mRNA expression was
undetectable using regular culture conditions no mat-
ter the amount or type of serum used (not shown) or
when the cells were treated with NE alone (Fig. 1A,
lanes 1 and 4). The combined addition of NE and T3 led
to increases in D2 mRNA expression (lane 3), in par-
allel with the findings for the adrenergic stimulation of
D2 activity (19), where T3 was a requirement for NE to
become effective whereas NE or T3 separately had no
effect. Moreover, in the absence of adrenergic stimula-
tion, prolonged exposure (40 h) to T3 increased D2
mRNA levels (2-fold) (Fig. 1A, lane 2), whereas short
exposures to T3 did not increase D2 mRNA (not
shown).
We also compared the effect of 24- and 72-h exposure
to T3 on D2 mRNA in cells treated with or without NE
(Fig. 1B). In the absence of NE, no effect was observed
after 24-h exposure to T3 (lane 1), whereas prolonged
exposure (72 h) to T3 increased D2 mRNA above basal
levels (lane 2). In the presence of NE, D2 mRNA in-
creased sixfold after a short exposure to T3 and a
further fivefold (a total of 30-fold) after a long (72 h)
exposure to T3 (lanes 3 and 4).
Fig. 1. A: adrenergic stimulation of 5-iodothyronine deiodinase (D2)
mRNA. Nine-day-old cultures of brown adipocytes were maintained
during the last 40 h in medium supplemented with 5% hypothyroid
serum (lane 4). Cells were cultured in the presence of 10 nM triiodo-
thyronine (T3) during the last 40 h (lane 2), 3 M norepinephrine (NE)
during the last 5 h (lane 1), or with 10 nM T3 for 40 h and 3 M NE for
5 h (lane 3). Seven micrograms of poly(A) RNA were loaded per lane.
D2 mRNA, cyclophilin (Cy) mRNA, and the D2-to-Cy ratio (D2/Cy) are
shown (means  SE from 3 experiments). B: effect of short and long
exposure time to T3 on the adrenergic induction of D2 mRNA. Nine-
day-old cultures of brown adipocytes were maintained during the last
72 h in medium supplemented with 5% hypothyroid serum. Cells were
cultured in the presence of 10 nM T3 during the last 24 or 72 h and in
the presence or absence of 5 M NE during the last 6 h. Five micro-
grams of poly(A) RNA were loaded per lane. Hybridization with a
cyclophilin cDNA was used to correct for differences between lanes and
D2/Cy is shown. Graph shows means  SE of 5 different experiments.
*P 
 0.05, vs. treated with only T3 for 72 h. C: RT-PCR assay. One
microgram of total RNA from 9-day-old cultures of brown adipocytes
was used for RT-PCR amplification. Cells were treated with 5% hypo-
thyroid serum, with 10 nM T3 for 24 or 72 h in the absence or presence
of 5 M NE during the last 6 h, or with NE alone. For each sample,
reactions were performed with (RT) and without (RT) reverse tran-
scriptase. As negative controls, mixtures with no RNA (C) or with
muscle RNA were run. PCR products were separated on an agarose gel,
transferred to a nylon membrane, and probed with a radiolabeled rat
D2 oligonucleotide. PCR products are shown after ethidium bromide
staining as well as the hybridization with the D2 oligonucletide probe.
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To see whether the NE response was too low to be
measured using poly(A) mRNA, we used RT-PCR
amplification, with 24- or 72-h exposure to T3, in the
presence or absence of NE (Fig. 1C). After RT-PCR
amplification, we observed essentially the same facts
as with poly(A) mRNA: NE alone was unable to in-
crease D2 mRNA (undetectable levels comparable to
basal levels or muscle), whereas NE T3 induced large
increases (24 or 72 h); T3 alone resulted in an interme-
diate response (lower, but detectable, at 24 h). Al-
though this technique amplifies exponentially any
small amount of DNA and does not allow a quantita-
tive approach, it confirms that T3 induces D2 mRNA
expression by itself besides amplifying the adrenergic
stimulation. With the use of NE alone, D2 induction is
undetectable.
Induction of D2 activity by NE and T3. In parallel, we
examined the adrenergic stimulation of D2 activity
using different exposure times to T3 (Fig. 2). The pres-
ence of T3 per se (or NE alone, Fig. 2, dashed line) did
not increase D2 activity. Adrenergic increases of D2
activity were larger in cells exposed to T3 from conflu-
ence (72 h) than in those exposed for a shorter time (24
h) to T3. The effect of T3 was also examined in the
absence of insulin, which increases D2 activity in BAT,
and the results were similar, although lower, indicat-
ing that the T3 effect is independent of insulin. The
increases observed in D2 activity after prolonged expo-
sure to T3 were modest compared with those observed
at the mRNA level.
Effect of high doses of T3. We then examined whether
high doses of T3 (100 nM) inhibit D2 mRNA in brown
adipocytes, as described in pituitary cells (25). Figure
3A shows that D2 mRNA expression is not suppressed
by a 100 nM dose of T3 in either the presence or
absence of NE. We further tested in the presence of NE
a larger T3 dose (500 nM), which did not inhibit D2
expression but induced further increases in D2 mRNA
(2.5-fold vs. 10 nM T3  NE). T3 concentrations were
very high, as measured by specific RIAs (50- and 250-
fold increases in the medium and cells, when 100 and
500 nM T3, respectively, were used vs. 10 nM T3). In
parallel, we tested whether these T3 doses inhibited D2
activity (Fig. 3B). Increasing amounts of T3 inhibited
the adrenergic stimulation of D2 activity, effects that
were detectable from 20 nM T3, and maximal inhibi-
tion was observed when using 100 nM T3.
Effect of adrenergic agonists. We have previously
shown (19) that, in cultured brown adipocytes, the
adrenergic responses of D2 activities were mediated
mainly by NE, whereas cAMP analogs did not repro-
duce the NE effect. The thermogenic responses in BAT
have been shown to be mediated via 3-adrenergic
receptors (55). We tested the effect of the 3-adrenergic
agonist BRL-37344, compared with NE and ISO, on D2
activity and D2 mRNA expression (Fig. 4, A and B).
Using dose-response curves, we observed that BRL-
37344 is more potent than NE and ISO at the dose of
0.1 M (P 
 0.05) in the stimulation of D2 activities
(half-maximal concentrations were 0.05 M for BRL-
Fig. 2. Effect of short and long exposure time to T3 on the adrenergic
induction of D2 activity. Eight-day-old cultures of brown adipocytes
were cultured in the presence of 10 nM T3 during the last 24 or 72 h
with or without NE (5 M) during the last 6 h by use of medium
supplemented with 10% hypothyroid serum. One-half of the cells was
cultured in insulin (Ins)-depleted medium for the last 24 h. Data are
means  SE (n  6) of 2–3 flasks from 2 different experiments. *P 

0.05, treated with T3 for 24 vs. 72 h. #P 
 0.05, vs. their respective
control cells.
Fig. 3. A: effect of high doses of T3 on the adrenergic induction of D2
mRNA. Brown adipocytes were cultured as described. Cells were
cultured in the presence of 10 or 100 (or 500) nM T3 during the last
72 h and in the presence or absence of 5 M NE during the last 6 h.
Five micrograms of poly(A) RNA were loaded per lane. Hybridiza-
tion with a cyclophilin cDNA was used to correct for differences
between lanes and D2/Cy is shown. Graph shows the mean  SE of
2 different experiments, with 10 nM T3  NE taken as 100%. B:
effect of high doses of T3 on the adrenergic induction of D2 activity.
Eight-day-old cultures of brown adipocytes were cultured in medium
supplemented with 10% hypothyroid serum in the presence of in-
creasing amounts of T3 (10, 20, 50, 100, 200, 500, and 1,000 nM)
during the last 24 h and NE (5 M) during the last 6 h. The values
from 10 nM T3  NE were taken as 100%. Line shows the values for
NE or T3 alone. Data are means  SE (n  4, done in triplicate) of 2
flasks from 2 different experiments. *P 
 0.05, vs. cells treated with
10 nM T3 for 24 h (100%).
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37344 vs. 0.2 M for NE and ISO). A plateau was
reached at higher concentrations.
With respect to D2 mRNA expression, similar levels
were detected with the use of equimolar concentrations
of NE or the 3-adrenergic agonist BRL-37344 in the
presence of T3 (Fig. 4B), although the latter seemed
slightly more potent (not significant). Additionally, we
tested the effect of 8-BrcAMP and found poor effects
compared with NE (P
 0.05 vs. NE; Fig. 4B). This is in
agreement with the low effect of cAMP analogs that we
reported for D2 activity (19).
D2 mRNA inductions are blocked by actinomycin D
and increased by cycloheximide. We studied whether
D2 mRNA adrenergic inductions were dependent on
increases in gene transcription and required de novo
protein synthesis. Cells were exposed for 1 or 3 days to
T3 and to NE for 7 h, in the presence or absence of
either actinomycin D (Act) or cycloheximide (CHX)
(both added 15 min before NE). We had previously
tested the complete inhibition of protein synthesis us-
ing these doses of CHX in culture (20). Addition of Act
or CHX for periods longer than 20 h was toxic for the
cells. Figure 5A shows that Act inhibits the induction
of D2 mRNA, suggesting that the adrenergic response
requires increases in gene transcription, whereas CHX
increases D2 mRNA levels, indicating that inhibition of
de novo protein synthesis for 7 h results in accumula-
tion of the D2 mRNA, especially of a short mRNA
species (1.9 kb). Similar results were obtained when
T3 was added for a short or a long time (NE) (Fig. 5A).
When both inhibitors were added to T3 alone (in the
absence of NE), the results were similar to those using
NE T3 (see Fig. 5B). Addition of CHX to cells in basal
conditions or using NE alone did not result in accumu-
lation of mRNA (data not shown), indicating that such
an accumulation is found only in the presence of T3.
D2 mRNA stability. We explored whether the effect
of T3 could be due to stabilization of D2 mRNA tran-
scripts leading to increases in its half-life, as this effect
of T3 is observed in other T3-dependent genes in brown
adipocytes, such as UCP1, malic enzyme, or S14 (3, 18,
20, 37).
To measure the stability of the D2 mRNA, brown
adipocytes were cultured in the presence of T3 for 1 or
3 days and exposed to NE (5 M) during the last 10 h
to stimulate D2 mRNA expression. Thereafter, Act was
added to some of the flasks, and cells were harvested at
different times for mRNA preparation. Because D2
mRNA expression was decreasing during this time, the
appropriate controls were run in parallel. Figure 6
shows first that, in the absence of Act, a decrease in D2
mRNA expression occurred during the period studied,
as the effect of NE decreased between 10 and 18 h, so
D2 mRNA expression decreased by 50% after 7 h, both
when T3 was added for long or short times (1 or 3 days).
Act induced a further reduction in D2 mRNA, but no
significant changes were observed between exposure to
T3 for 1 or 3 days. D2 mRNA half-life was 6 h, so the
Fig. 5. Effect of actinomycin D (Act) and cycloheximide (CHX) on D2
mRNA. A: by use of NE and T3 for 1 or 3 days, 9-day-old cultures of
brown adipocytes were maintained during the last 72 h in medium
supplemented with 5% hypothyroid serum. Cells were cultured in
the presence of 10 nM T3 during the last 24 or 72 h, and 5 M NE was
added during the last 7 h. Act (5 g/ml) or CHX (25 M) was added
15 min before NE. Five micrograms of poly(A) RNA were loaded per
lane. Hybridization with a cyclophilin cDNA was used to correct for
differences between lanes and D2/Cy is shown (mean  SE from 3
experiments). B: with T3 alone, the same protocol was used as in A,
except that T3 was added for 72 h (without NE), and Act (5 g/ml) or
CHX (15 M) was added during the last 14 h (mean  SE from 2
experiments).
Fig. 4. A: dose-response curves for the adrenergic stimulation of D2
activity using NE, isoproterenol (ISO), and BRL-37344 (BRL). Eight-
day-old cultures of brown adipocytes were maintained during the
last 24 h in medium supplemented with 10% hypothyroid serum and
10 nM T3. Cells were exposed to different concentrations of NE, ISO,
and BRL during the last 6 h. Data are means  SE (n  4,
triplicates) of 2 flasks from 2 different experiments. *P 
 0.05, BRL
vs. NE. B: adrenergic stimulation of D2 mRNA using NE, BRL, and
8-bromoadenosine 3,5-cyclic monophosphate (8-BrcAMP). Nine-
day-old cultures of brown adipocytes were maintained during the
last 72 h in medium supplemented with 5% hypothyroid serum. T3
(10 nM) was added during the last 24 h, and 0.2 M NE or BRL or 0.5
mM 8-BrcAMP was added during the last 6 h. Five micrograms of
poly(A) RNA were loaded per lane. D2 mRNA, cyclophilin mRNA,
and D2/Cy are shown (mean  SE of two experiments).
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presence of T3 for short or long times does not seem to
play a role in increasing D2 mRNA stability. Neverthe-
less, as we cannot measure D2 mRNA half-life in the
absence of T3, it is likely that T3 is playing a role in the
stabilization of D2 mRNA transcripts.
DISCUSSION
The main regulator of D2 activity in BAT is cold
exposure, via the adrenergic stimulation (44), a situa-
tion in which D2 provides the T3 required for the full
expression of UCP1, the specific marker of BAT (5). T3
plays other important roles in brown adipocytes, in-
creasing mitocondriogenesis, the expression of lipo-
genic markers (18, 37), and favoring differentiation
programs. The action of T3 on D2 expression does not
seem to be an indirect effect linked to the differentia-
tion program, but rather an action required for the NE
action.
NE. D2 is stimulated adrenergically in floating adi-
pocytes (32), and a synergy between the - and 1-
adrenergic pathways was found (38), the adrenergic
stimulation of D2 being mostly -adrenergic in mouse
brown adipocytes (35). We have shown that T3 is an
absolute requirement for the adrenergic stimulation of
D2 and amplifies this response (19).
In the present study, we analyzed the mechanisms
involved in the stimulation of D2 mRNA expression by
use of rat brown adipocytes in culture. A predominant
band of 7.5 kb and several other weaker bands were
observed for D2 mRNA, as described (12). Using
poly(A), we did not detect D2 mRNA in basal condi-
tions or when adding NE alone. Using an RT-PCR
technique, we were also unable to detect increases in
D2 mRNA in response to NE alone, and the presence of
T3 was required. This lack of response could be due to
the hypothyroidism-induced impairment of the -ad-
renergic response that results in a lower density of
1-adrenergic receptors (AR), and lower cAMP levels
(both decreased by 60%) (40). This effect of hypothy-
roidism has been reported for many tissues (51) and
recently has been addressed extensively in BAT for 1-,
2-, and 3-AR (40, 41). Treatment with T3 slowly
restores first the density of 1-AR and later the capac-
ity to produce cAMP, suggesting that the lower cAMP
production reflects a fault at the postreceptor level
(40). Nevertheless genes such as UCP1, which are
stimulated adrenergically and whose expression is low
in hypothyroid rats, restore their levels a few hours
after T3 injection (4), much before cAMP production is
normalized. The lack of response to NE and the T3
requirement for NE action goes much further than the
simple restoration of the 1-AR density. Moreover, the
changes in 3-AR density in response to hypothyroid-
ism and T3 are opposite to the ones observed for 1-AR
density (41).
Indeed, a cAMP response element (CRE) has been
identified in the 5 UT region of the human D2 pro-
moter (92/85) (1), and D2 mRNA responds quickly
to forskolin and 8-BrcAMP in astrocytes (34), indicat-
ing that CRE seems to be an important regulatory
element in the D2 promoter. To our knowledge, no
functional CRE has been identified yet in the rat D2
promoter.
T3 and NE. The adrenergic stimulation of D2 mRNA
in cultured brown adipocytes requires the presence of
T3. This finding is similar to what is found for the
adrenergic stimulation of UCP1 mRNA, where a syn-
ergy between NE and T3 is required, postulated to be
exerted via CREs. In the UCP1 gene, an enhancer
region has been found that has several thyroid re-
sponse elements, retinoic acid response elements, and
possibly peroxisome proliferator-activated response el-
ements that synergized with the response of NE via
cAMP. The cooperative interaction between the T3 and
NE actions is firmly stablished (3, 4), but the specific
proteins involved (coactivators) have not yet been iden-
tified. The recruitment of coactivators would increase
the affinity or phosphorylation of CCAAT/enhancer-
binding protein/p300 to increase transcription. An-
other possible candidate is PGC-1, the coactivator 1 for
peroxisome proliferator-activated receptor-	 (PPAR	),
induced in BAT upon cold exposure. The participation
Fig. 6. Determination of half-life of D2 mRNA. Nine-day-old cultures of brown adipocytes were maintained during
the last 72 h in medium supplemented with 5% hypothyroid serum. Cells were cultured in the presence of 10 nM
T3 during the last 72 or 24 h (circles and triangles, respectively), and 5 M NE was added during the last 10 h.
Thereafter, Act (5 g/ml) was added and cells harvested at 3, 5, and 7 h. The natural decrease in D2 mRNA
expression at 5 and 7 h is shown (filled symbols and solid lines) as well as Act-treated cells (open symbols and
dashed lines). Five micrograms of poly(A) RNA were loaded per lane. Hybridization with a cyclophilin cDNA was
used to correct for differences between lanes. Figure shows the mean  SE from 3 different experiments.
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of these proteins in the synergistic action of NE and
T3 is not elucidated. Recent reports using mice with
targeted disruption of the D2 gene suggest that the
T3 derived from D2 is essential for the thyroid-
sympathetic synergy required for adaptative thermo-
genesis (15).
The adrenergic responses behave as 3-adrenergic at
the mRNA level, in agreement with previous reports
using CGP-12177A (19, 35), and the responses are
similar for D2 activity and mRNA. The effect of NE on
D2 activity and mRNA is only poorly reproduced when
using 8-BrcAMP (19). This suggests either that cAMP
by itself is not the only pathway of activation or that T3
interferes in its transduction pathway. Other signaling
pathways, such as p38 mitogen-activated protein ki-
nase, have been recently reported to be activated in
response to 3-agonists in brown adipocytes, indicating
the need for this signaling pathway, in addition to
elevation of cAMP levels (8). We have measured cAMP
levels in our cells (unpublished results), which increase
with the use of NE, BRL-37344, or other 3-agonists to
levels comparable to those obtained using 8-BrcAMP
(150–200 up to 500 pmol cAMP/mg protein), levels that
increase twofold in the presence of T3. The possibility
that the CRE is inhibited by the action of serum, via
c-jun, as has been described in the UCP1 promoter
(54), is unlikely, because we find no response to NE
either in the absence of serum.
T3. In addition, we have demonstrated that T3 by
itself increases D2 mRNA expression. Although the
extent of this increase may seem modest, it is an
unexpected finding. The increased D2 mRNA expres-
sion observed with the use of T3 could be due to direct
stimulation of transcription (as Act blunts it), stimula-
tion of factors required for transcription, or stabiliza-
tion of the preexisting mRNA, as the T3 effect requires
long times to be observed. T3 could also stimulate basal
D2 expression by increasing the basal adenylyl cyclase
activity, as T3 reduces Gi levels (9). Nevertheless, basal
cAMP levels are not modified by addition of T3 in our
cells. Of note, RT-PCR is able to amplify D2 transcripts
after 24 h of T3 treatment alone, a fact not observed
when NE is used alone.
This effect of T3 is in contrast to what is found in vivo
in other tissues such as brain (7, 12, 26) or pituitary
cells (25), where T3 inhibits D2 mRNA by 50%, sug-
gesting specific modulation of D2 in each cell. The
inhibition of D2 activity by T3 is much lower than that
of T4 and reverse T3 (47, 48). In BAT, T3 has little
ability, if any, in inhibiting D2 activity and even 2-fold
increases were reported (47). We found that constant
infusion of T3 into rats stimulated D2 activity in BAT
and brain from fetal and adult rats (16, 31). In the
present study, we observe clear inhibition of D2 activ-
ity when using 20 nM T3 or higher, but at the mRNA
level, we do not observe decreases in D2 expression,
even when very high T3 doses are used, and further
increases in D2 mRNA are observed with the use of 500
nM T3 (a T3 dose that increase T3 concentrations250-
fold in cells and medium).
Mechanisms. The experiments done using CHX
and Act indicate that D2 mRNA induction using
NE  T3 or T3 is activated at the transcriptional
level and that the inhibition of de novo protein syn-
thesis results in accumulation of mRNA, especially
of a shorter mRNA species. CHX treatment of T3-
exposed cells produces a marked increase in a 1.9-kb
mRNA species that was barely detectable in control
cells (Fig. 5). This transcript might be a short-lived
product generated by alternative mRNA processing.
The nature of this mRNA is unknown, but it might
correspond to a 1.9-kb D2 cDNA isolated from brown
fat (12) that does not code for an active protein
because it is lacking a putative SECIS element. If
this is the case, expression of this shorter mRNA
might be an important regulatory mechanism of ex-
pression of active D2 enzyme. The accumulation of
D2 mRNA with the use of CHX has been reported in
pituitary cells (25) (mRNAs sizes were not described)
and in pineal glands, where a short band is also
observed (22). Of note, CHX per se, or in the presence
of NE without T3, is unable to accumulate shorter or
larger mRNA species (results not shown).
The studies performed to determine whether a pro-
longed exposure to T3 contributes to increases in D2
mRNA half-life suggest that this is not the case. Nev-
ertheless, we do not exclude the possibility that T3 is
inducing a stabilization of the D2 mRNA transcripts,
as we were unable to measure D2 mRNA half-life in
the absence of T3. A much shorter D2 mRNA half-life (2
h instead of the 6 h we find) has been reported in
pituitary cells (25), suggesting that the presence of T3
might increase D2 mRNA half-life.
In summary, we have demonstrated that T3 is an
absolute requirement for the adrenergic stimulation of
D2 mRNA (and activity) in brown adipocytes. This
stimulation occurs mainly via 3-adrenergic receptors.
T3 by itself is able to increase D2 mRNA after pro-
longed exposure, and its presence is required for the
accumulation of D2 mRNA species after treatment
with CHX. Additional work is necessary to elucidate
the mechanisms by which this novel role of T3 takes
place. The findings reported here are important, as D2
mRNA expression has not been studied in brown adi-
pocytes, and give a new dimension to the important
role of T3 in the regulation and maintenance of its own
production in BAT besides its importance in the stim-
ulation of the thermogenic function, namely the ex-
pression of UCP1, the specific marker of brown adipo-
cytes.
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